Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.

von Minckwitz G, Colleoni M, Kolberg HC, Morales S, Santi P, Tomasevic Z, Zhang N, Hanes V.

Lancet Oncol. 2018 Jun 4. pii: S1470-2045(18)30241-9. doi: 10.1016/S1470-2045(18)30241-9. [Epub ahead of print]

PMID:
29880292
2.

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients.

Keup C, Mach P, Aktas B, Tewes M, Kolberg HC, Hauch S, Sprenger-Haussels M, Kimmig R, Kasimir-Bauer S.

Clin Chem. 2018 Jul;64(7):1054-1062. doi: 10.1373/clinchem.2017.283531. Epub 2018 May 16.

PMID:
29769179
3.

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study.

Nabieva N, Fehm T, Häberle L, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Popovic M, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Hack CC, Schmidt K, Belleville E, Brucker SY, Kümmel S, Beckmann MW, Wallwiener D, Hadji P, Fasching PA.

Eur J Cancer. 2018 Jun;96:82-90. doi: 10.1016/j.ejca.2018.03.020. Epub 2018 Apr 18.

PMID:
29679775
4.

Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.

Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN.

Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21.

5.

Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers.

Taran FA, Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Fasching PA, Fehm TN, Schütz F.

Geburtshilfe Frauenheilkd. 2018 Mar;78(3):237-245. doi: 10.1055/s-0044-101613. Epub 2018 Mar 21.

6.

Update Breast Cancer 2017 - Implementation of Novel Therapies.

Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Ettl J, Huober JB, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A, Fasching PA.

Geburtshilfe Frauenheilkd. 2017 Dec;77(12):1281-1290. doi: 10.1055/s-0043-122885. Epub 2017 Dec 18.

7.

Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry.

Müller V, Nabieva N, Häberle L, Taran FA, Hartkopf AD, Volz B, Overkamp F, Brandl AL, Kolberg HC, Hadji P, Tesch H, Ettl J, Lux MP, Lüftner D, Belleville E, Fasching PA, Janni W, Beckmann MW, Wimberger P, Hielscher C, Fehm TN, Brucker SY, Wallwiener D, Schneeweiss A, Wallwiener M.

Breast. 2018 Feb;37:154-160. doi: 10.1016/j.breast.2017.08.008. Epub 2017 Dec 10.

PMID:
29237546
8.

Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer.

Kolberg HC, Lövey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Hoffmann O, Bulsara M, Vaidya J, Liedtke C.

Breast Care (Basel). 2017 Oct;12(5):318-323. doi: 10.1159/000479424. Epub 2017 Sep 21.

PMID:
29234252
9.

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.

Hartkopf AD, Huober J, Volz B, Nabieva N, Taran FA, Schwitulla J, Overkamp F, Kolberg HC, Hadji P, Tesch H, Häberle L, Ettl J, Lux MP, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wimberger P, Hielscher C, Geberth M, Fersis N, Abenhardt W, Kurbacher C, Wuerstlein R, Thomssen C, Untch M, Fasching PA, Janni W, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A.

Breast. 2018 Feb;37:42-51. doi: 10.1016/j.breast.2017.10.002. Epub 2017 Oct 26.

PMID:
29100043
10.

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients.

Nabieva N, Kellner S, Fehm T, Häberle L, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Brucker SY, Kümmel S, Beckmann MW, Wallwiener D, Hadji P, Fasching PA.

Ann Oncol. 2018 Jan 1;29(1):186-192. doi: 10.1093/annonc/mdx630.

PMID:
29045642
11.

An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer-Experiences After 150 Cases.

Kolberg HC, Afsah S, Kuehn T, Winzer U, Akpolat-Basci L, Stephanou M, Wetzig S, Hoffmann O, Liedtke C.

Technol Cancer Res Treat. 2017 Jan 1:1533034617728862. doi: 10.1177/1533034617728862. [Epub ahead of print]

12.

Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.

Wallwiener M, Heindl F, Brucker SY, Taran FA, Hartkopf A, Overkamp F, Kolberg HC, Hadji P, Tesch H, Ettl J, Lux MP, Rauh C, Blum S, Nabieva N, Brodkorb TF, Faschingbauer C, Langemann H, Schulmeyer C, Volz B, Rübner M, Lüftner D, Müller V, Belleville E, Janni W, Fehm TN, Wallwiener D, Ganslandt T, Beckmann MW, Schneeweiss A, Fasching PA, Gass P.

Geburtshilfe Frauenheilkd. 2017 Aug;77(8):870-878. doi: 10.1055/s-0043-116223. Epub 2017 Aug 24.

13.

Editorial: Primary Systemic Therapy for Breast Cancer.

Kolberg HC.

Rev Recent Clin Trials. 2017;12(2):66. doi: 10.2174/157488711202170510202553. No abstract available.

PMID:
28825398
14.

Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.

Bredemeier M, Kasimir-Bauer S, Kolberg HC, Herold T, Synoracki S, Hauch S, Edimiris P, Bankfalvi A, Tewes M, Kimmig R, Aktas B.

Mol Med Rep. 2017 May;15(5):2957-2968. doi: 10.3892/mmr.2017.6415. Epub 2017 Mar 30.

15.

Breast cancer and genomic testing.

Liedtke C, Kolberg HC.

Br J Surg. 2017 Jun;104(7):799-801. doi: 10.1002/bjs.10513. Epub 2017 Mar 16. No abstract available.

PMID:
28300277
16.

Transvaginal PVDF-mesh for cystocele repair: A cohort study.

Barski D, Arndt C, Gerullis H, Yang J, Boros M, Otto T, Kolberg HC.

Int J Surg. 2017 Mar;39:249-254. doi: 10.1016/j.ijsu.2017.02.006. Epub 2017 Feb 10.

PMID:
28192248
17.

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.

Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching PA, Untch M, Bulsara M, Vaidya JS, Liedtke C.

Rev Recent Clin Trials. 2017;12(2):93-100. doi: 10.2174/1574887112666170201142458.

PMID:
28155607
18.

Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer.

Kolberg HC, Aktas B, Liedtke C.

Rev Recent Clin Trials. 2017;12(2):67-72. doi: 10.2174/1574887112666170201143321. Review.

PMID:
28155606
19.

Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over 4 Years.

Kolberg HC, Akpolat-Basci L, Stephanou M, Aktas B, Hannig CV, Liedtke C.

Breast Care (Basel). 2016 Oct;11(5):323-327. Epub 2016 Oct 24.

20.

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

Gaß P, Fasching PA, Fehm T, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Brucker SY, Beckmann MW, Wallwiener D, Kümmel S, Löhberg CR.

Breast Care (Basel). 2016 Oct;11(5):315-322. Epub 2016 Oct 27.

21.

Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.

Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching PA, Untch M, Liedtke C, Bulsara M, Vaidya JS.

Strahlenther Onkol. 2017 Jan;193(1):62-69. doi: 10.1007/s00066-016-1072-y. Epub 2016 Nov 17.

PMID:
27858093
22.

Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.

Waldrep AR, Avery EJ, Rose FF Jr, Midathada MV, Tilford JA, Kolberg HC, Hutchins MR.

Anticancer Res. 2016 Oct;36(10):5389-5395.

PMID:
27798904
23.

Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts.

Liedtke C, Kolberg HC.

Breast Care (Basel). 2016 Aug;11(4):275-281. Epub 2016 Jul 28. Review.

24.

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

Hack CC, Fasching PA, Fehm T, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Brucker SY, Wallwiener D, Kümmel S, Beckmann MW, Paepke D.

Integr Cancer Ther. 2017 Jun;16(2):165-175. doi: 10.1177/1534735416668575. Epub 2016 Sep 14.

25.

Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, Sartori A, Stier C, Lakdawala M, Bhasker AG, Buchwald H, Dixon J, Chiappetta S, Kolberg HC, Frühbeck G, Sarwer DB, Suter M, Soricelli E, Blüher M, Vilallonga R, Sharma A, Shikora S.

Obes Surg. 2016 Aug;26(8):1659-96. doi: 10.1007/s11695-016-2271-4. No abstract available.

26.

Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.

Hein A, Gass P, Walter CB, Taran FA, Hartkopf A, Overkamp F, Kolberg HC, Hadji P, Tesch H, Ettl J, Wuerstlein R, Lounsbury D, Lux MP, Lüftner D, Wallwiener M, Müller V, Belleville E, Janni W, Fehm TN, Wallwiener D, Ganslandt T, Ruebner M, Beckmann MW, Schneeweiss A, Fasching PA, Brucker SY.

Breast Cancer Res Treat. 2016 Jul;158(1):59-65. doi: 10.1007/s10549-016-3850-8. Epub 2016 Jun 9.

PMID:
27283834
27.

Current Medical Treatment of Patients with Non-Colorectal Liver Metastases: Primary Tumor Breast Cancer.

Liedtke C, Kolberg HC.

Viszeralmedizin. 2015 Dec;31(6):424-32. doi: 10.1159/000441961. Epub 2015 Dec 3. Review.

28.

Relatedness predicts multiple measures of investment in cooperative nest construction in sociable weavers.

Leighton GM, Echeverri S, Heinrich D, Kolberg H.

Behav Ecol Sociobiol. 2015 Nov 1;69(11):1835-1843. Epub 2015 Aug 29.

29.

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival.

Kern P, Kalisch A, von Minckwitz G, Pütter C, Kolberg HC, Pott D, Kurbacher C, Rezai M, Kimmig R.

J Chemother. 2016 Jun;28(3):210-7. doi: 10.1179/1973947815Y.0000000061. Epub 2016 May 27.

PMID:
26239282
30.

Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study.

Halfter K, Ditsch N, Kolberg HC, Fischer H, Hauzenberger T, von Koch FE, Bauerfeind I, von Minckwitz G, Funke I, Crispin A, Mayer B; Behalf of the SpheroNEO Study Group.

BMC Cancer. 2015 Jul 15;15:519. doi: 10.1186/s12885-015-1491-7.

31.

Declines in migrant shorebird populations from a winter-quarter perspective.

Simmons RE, Kolberg H, Braby R, Erni B.

Conserv Biol. 2015 Jun;29(3):877-87. doi: 10.1111/cobi.12493. Epub 2015 Apr 9.

PMID:
25858334
32.

Breast Cancer Update 2014 - Focus on the Patient and the Tumour.

Maass N, Schütz F, Fasching PA, Fehm T, Janni W, Kümmel S, Kolberg HC, Lüftner D, Wallwiener M, Lux MP.

Geburtshilfe Frauenheilkd. 2015 Feb;75(2):170-182.

33.

Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study.

Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY.

Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143.

34.

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete response.

Kern P, Kalisch A, Kolberg HC, Kimmig R, Otterbach F, von Minckwitz G, Sikov WM, Pott D, Kurbacher C.

Chemotherapy. 2013;59(5):387-94. doi: 10.1159/000362756. Epub 2014 May 13.

35.

Advances in Breast Cancer - Looking Back over the Year.

Lüftner D, Lux MP, Maass N, Schütz F, Schwidde I, Fasching PA, Fehm T, Janni W, Kümmel S, Kolberg HC.

Geburtshilfe Frauenheilkd. 2012 Dec;72(12):1117-1129.

36.

Breast Cancer 2012 - New Aspects.

Kolberg HC, Lüftner D, Lux MP, Maass N, Schütz F, Fasching PA, Fehm T, Janni W, Kümmel S.

Geburtshilfe Frauenheilkd. 2012 Jul;72(7):602-615.

37.

Characterisation of the promoter region of the human DNA-repair gene Rad51.

Hasselbach L, Haase S, Fischer D, Kolberg HC, Stürzbecher HW.

Eur J Gynaecol Oncol. 2005;26(6):589-98. Review.

PMID:
16398215
38.

Epidermal cyst of the breast mimicking malignancy: clinical, radiological, and histological correlation.

Bergmann-Koester CU, Kolberg HC, Rudolf I, Krueger S, Gellissen J, Stoeckelhuber BM.

Arch Gynecol Obstet. 2006 Feb;273(5):312-4. Epub 2005 Nov 18.

PMID:
16328396
40.

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients.

Qiao GB, Wu YL, Yang XN, Zhong WZ, Xie D, Guan XY, Fischer D, Kolberg HC, Kruger S, Stuerzbecher HW.

Br J Cancer. 2005 Jul 11;93(1):137-43.

41.

[Treatment results following breast-conserving therapy in primary breast cancer].

Fehlauer F, Weinhold HD, Kolberg HC, Lindenkamp M, Schulte R, Mahlmann B, Richter E, Feyerabend T.

Zentralbl Gynakol. 2005 Feb;127(1):31-6. German.

PMID:
15702448
42.

Taxanes in the first-line chemotherapy of metastatic breast cancer: review.

Friedrich M, Diesing D, Villena-Heinsen C, Felberbaum R, Kolberg HC, Diedrich K.

Eur J Gynaecol Oncol. 2004;25(1):66-70. Review.

PMID:
15053065
43.

Benign cystitis in children mimicking rhabdomyosarcoma.

Rosenberg HK, Eggli KD, Zerin JM, Ortega W, Wallach MT, Kolberg H, Lebowitz RL, Snyder HM.

J Ultrasound Med. 1994 Dec;13(12):921-32.

PMID:
7877202
44.

Normal splenic size in infants and children: sonographic measurements.

Rosenberg HK, Markowitz RI, Kolberg H, Park C, Hubbard A, Bellah RD.

AJR Am J Roentgenol. 1991 Jul;157(1):119-21.

PMID:
2048509
45.

Studies on parotid saliva in cystic fibrosis.

Kolberg H, Danielsson A, Glitterstam K, Henriksson R, Marklund S.

Acta Paediatr Scand. 1982 Mar;71(2):321-2. No abstract available.

PMID:
6182737
46.

Epidural analgesia for post-thoracotomy patients.

James EC, Kolberg HL, Iwen GW, Gellatly TA.

J Thorac Cardiovasc Surg. 1981 Dec;82(6):898-903.

PMID:
7300419
47.

[Antitussive effects of an aminonitrile].

CHRISTOFFEL P, KOLBERG H.

Med Klin. 1958 Aug 29;53(35):1507-9. No abstract available.

PMID:
13589549

Supplemental Content

Loading ...
Support Center